The a2 Milk Company Limited
The a2 Milk Company Limited (ACOPY) Stock Competitors & Peer Comparison
See (ACOPY) competitors and their performances in Stock Market.
Peer Comparison Table: Packaged Foods Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ACOPY | $4.55 | -4.01% | 3.3B | 25.16 | $0.18 | +2.98% |
| NSRGY | $99.65 | +1.68% | 254.3B | 21.97 | $4.50 | +4.05% |
| NSRGF | $99.96 | +0.34% | 253.4B | 21.85 | $4.51 | +4.02% |
| DANOY | $14.60 | +1.53% | 45.6B | 21.61 | $0.66 | +3.66% |
| GPDNF | $73.12 | +1.81% | 45.1B | 20.98 | $3.36 | +3.74% |
| AJINF | $33.00 | -6.41% | 32B | 37.99 | $0.88 | +0.99% |
| JBSAY | $13.81 | +3.06% | 30.6B | 6.94 | $1.99 | +2.48% |
| ASBFF | $25.76 | +0.00% | 18B | 13.35 | $1.93 | +3.28% |
| JDEPF | $36.39 | +0.00% | 17.7B | 19.25 | $1.89 | +1.16% |
| ASBFY | $24.76 | +2.34% | 16.9B | 13.29 | $1.81 | +3.53% |
Stock Comparison
ACOPY vs NSRGY Comparison May 2026
ACOPY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPY stands at 3.3B. In comparison, NSRGY has a market cap of 254.3B. Regarding current trading prices, ACOPY is priced at $4.55, while NSRGY trades at $99.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPY currently has a P/E ratio of 25.16, whereas NSRGY's P/E ratio is 21.97. In terms of profitability, ACOPY's ROE is +0.16%, compared to NSRGY's ROE of +0.29%. Regarding short-term risk, ACOPY is less volatile compared to NSRGY. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPY.Check NSRGY's competition here
ACOPY vs NSRGF Comparison May 2026
ACOPY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPY stands at 3.3B. In comparison, NSRGF has a market cap of 253.4B. Regarding current trading prices, ACOPY is priced at $4.55, while NSRGF trades at $99.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPY currently has a P/E ratio of 25.16, whereas NSRGF's P/E ratio is 21.85. In terms of profitability, ACOPY's ROE is +0.16%, compared to NSRGF's ROE of +0.29%. Regarding short-term risk, ACOPY is less volatile compared to NSRGF. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPY.Check NSRGF's competition here
ACOPY vs DANOY Comparison May 2026
ACOPY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPY stands at 3.3B. In comparison, DANOY has a market cap of 45.6B. Regarding current trading prices, ACOPY is priced at $4.55, while DANOY trades at $14.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPY currently has a P/E ratio of 25.16, whereas DANOY's P/E ratio is 21.61. In terms of profitability, ACOPY's ROE is +0.16%, compared to DANOY's ROE of +0.11%. Regarding short-term risk, ACOPY is less volatile compared to DANOY. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPY.Check DANOY's competition here
ACOPY vs GPDNF Comparison May 2026
ACOPY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPY stands at 3.3B. In comparison, GPDNF has a market cap of 45.1B. Regarding current trading prices, ACOPY is priced at $4.55, while GPDNF trades at $73.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPY currently has a P/E ratio of 25.16, whereas GPDNF's P/E ratio is 20.98. In terms of profitability, ACOPY's ROE is +0.16%, compared to GPDNF's ROE of +0.11%. Regarding short-term risk, ACOPY and GPDNF have similar daily volatility (0.00).Check GPDNF's competition here
ACOPY vs AJINF Comparison May 2026
ACOPY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPY stands at 3.3B. In comparison, AJINF has a market cap of 32B. Regarding current trading prices, ACOPY is priced at $4.55, while AJINF trades at $33.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPY currently has a P/E ratio of 25.16, whereas AJINF's P/E ratio is 37.99. In terms of profitability, ACOPY's ROE is +0.16%, compared to AJINF's ROE of +0.18%. Regarding short-term risk, ACOPY and AJINF have similar daily volatility (0.00).Check AJINF's competition here
ACOPY vs JBSAY Comparison May 2026
ACOPY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPY stands at 3.3B. In comparison, JBSAY has a market cap of 30.6B. Regarding current trading prices, ACOPY is priced at $4.55, while JBSAY trades at $13.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPY currently has a P/E ratio of 25.16, whereas JBSAY's P/E ratio is 6.94. In terms of profitability, ACOPY's ROE is +0.16%, compared to JBSAY's ROE of +0.20%. Regarding short-term risk, ACOPY is less volatile compared to JBSAY. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPY.Check JBSAY's competition here
ACOPY vs ASBFF Comparison May 2026
ACOPY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPY stands at 3.3B. In comparison, ASBFF has a market cap of 18B. Regarding current trading prices, ACOPY is priced at $4.55, while ASBFF trades at $25.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPY currently has a P/E ratio of 25.16, whereas ASBFF's P/E ratio is 13.35. In terms of profitability, ACOPY's ROE is +0.16%, compared to ASBFF's ROE of +0.08%. Regarding short-term risk, ACOPY and ASBFF have similar daily volatility (0.00).Check ASBFF's competition here
ACOPY vs JDEPF Comparison May 2026
ACOPY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPY stands at 3.3B. In comparison, JDEPF has a market cap of 17.7B. Regarding current trading prices, ACOPY is priced at $4.55, while JDEPF trades at $36.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPY currently has a P/E ratio of 25.16, whereas JDEPF's P/E ratio is 19.25. In terms of profitability, ACOPY's ROE is +0.16%, compared to JDEPF's ROE of +0.07%. Regarding short-term risk, ACOPY is less volatile compared to JDEPF. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPY.Check JDEPF's competition here
ACOPY vs ASBFY Comparison May 2026
ACOPY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPY stands at 3.3B. In comparison, ASBFY has a market cap of 16.9B. Regarding current trading prices, ACOPY is priced at $4.55, while ASBFY trades at $24.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPY currently has a P/E ratio of 25.16, whereas ASBFY's P/E ratio is 13.29. In terms of profitability, ACOPY's ROE is +0.16%, compared to ASBFY's ROE of +0.08%. Regarding short-term risk, ACOPY is less volatile compared to ASBFY. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPY.Check ASBFY's competition here
ACOPY vs WHGLY Comparison May 2026
ACOPY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPY stands at 3.3B. In comparison, WHGLY has a market cap of 15.3B. Regarding current trading prices, ACOPY is priced at $4.55, while WHGLY trades at $23.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPY currently has a P/E ratio of 25.16, whereas WHGLY's P/E ratio is 9.75. In terms of profitability, ACOPY's ROE is +0.16%, compared to WHGLY's ROE of +0.14%. Regarding short-term risk, ACOPY is less volatile compared to WHGLY. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPY.Check WHGLY's competition here
ACOPY vs GRBMF Comparison May 2026
ACOPY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPY stands at 3.3B. In comparison, GRBMF has a market cap of 14.7B. Regarding current trading prices, ACOPY is priced at $4.55, while GRBMF trades at $3.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPY currently has a P/E ratio of 25.16, whereas GRBMF's P/E ratio is 21.38. In terms of profitability, ACOPY's ROE is +0.16%, compared to GRBMF's ROE of +0.10%. Regarding short-term risk, ACOPY is less volatile compared to GRBMF. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPY.Check GRBMF's competition here
ACOPY vs BMBOY Comparison May 2026
ACOPY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPY stands at 3.3B. In comparison, BMBOY has a market cap of 14.6B. Regarding current trading prices, ACOPY is priced at $4.55, while BMBOY trades at $13.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPY currently has a P/E ratio of 25.16, whereas BMBOY's P/E ratio is 21.58. In terms of profitability, ACOPY's ROE is +0.16%, compared to BMBOY's ROE of +0.10%. Regarding short-term risk, ACOPY and BMBOY have similar daily volatility (0.00).Check BMBOY's competition here
ACOPY vs AJINY Comparison May 2026
ACOPY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPY stands at 3.3B. In comparison, AJINY has a market cap of 14.4B. Regarding current trading prices, ACOPY is priced at $4.55, while AJINY trades at $28.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPY currently has a P/E ratio of 25.16, whereas AJINY's P/E ratio is 117.46. In terms of profitability, ACOPY's ROE is +0.16%, compared to AJINY's ROE of +0.11%. Regarding short-term risk, ACOPY is less volatile compared to AJINY. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPY.Check AJINY's competition here
ACOPY vs WHGRF Comparison May 2026
ACOPY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPY stands at 3.3B. In comparison, WHGRF has a market cap of 13.6B. Regarding current trading prices, ACOPY is priced at $4.55, while WHGRF trades at $1.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPY currently has a P/E ratio of 25.16, whereas WHGRF's P/E ratio is 8.83. In terms of profitability, ACOPY's ROE is +0.16%, compared to WHGRF's ROE of +0.14%. Regarding short-term risk, ACOPY is less volatile compared to WHGRF. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPY.Check WHGRF's competition here
ACOPY vs KRYAY Comparison May 2026
ACOPY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPY stands at 3.3B. In comparison, KRYAY has a market cap of 13.5B. Regarding current trading prices, ACOPY is priced at $4.55, while KRYAY trades at $85.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPY currently has a P/E ratio of 25.16, whereas KRYAY's P/E ratio is 18.00. In terms of profitability, ACOPY's ROE is +0.16%, compared to KRYAY's ROE of +0.11%. Regarding short-term risk, ACOPY is less volatile compared to KRYAY. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPY.Check KRYAY's competition here
ACOPY vs KRYAF Comparison May 2026
ACOPY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPY stands at 3.3B. In comparison, KRYAF has a market cap of 13.3B. Regarding current trading prices, ACOPY is priced at $4.55, while KRYAF trades at $85.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPY currently has a P/E ratio of 25.16, whereas KRYAF's P/E ratio is 17.70. In terms of profitability, ACOPY's ROE is +0.16%, compared to KRYAF's ROE of +0.09%. Regarding short-term risk, ACOPY and KRYAF have similar daily volatility (0.00).Check KRYAF's competition here
ACOPY vs ORKLY Comparison May 2026
ACOPY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPY stands at 3.3B. In comparison, ORKLY has a market cap of 11.8B. Regarding current trading prices, ACOPY is priced at $4.55, while ORKLY trades at $12.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPY currently has a P/E ratio of 25.16, whereas ORKLY's P/E ratio is 17.33. In terms of profitability, ACOPY's ROE is +0.16%, compared to ORKLY's ROE of +0.24%. Regarding short-term risk, ACOPY is less volatile compared to ORKLY. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPY.Check ORKLY's competition here
ACOPY vs ORKLF Comparison May 2026
ACOPY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPY stands at 3.3B. In comparison, ORKLF has a market cap of 11.8B. Regarding current trading prices, ACOPY is priced at $4.55, while ORKLF trades at $11.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPY currently has a P/E ratio of 25.16, whereas ORKLF's P/E ratio is 17.29. In terms of profitability, ACOPY's ROE is +0.16%, compared to ORKLF's ROE of +0.24%. Regarding short-term risk, ACOPY is less volatile compared to ORKLF. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPY.Check ORKLF's competition here
ACOPY vs SAPIF Comparison May 2026
ACOPY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPY stands at 3.3B. In comparison, SAPIF has a market cap of 11.7B. Regarding current trading prices, ACOPY is priced at $4.55, while SAPIF trades at $28.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPY currently has a P/E ratio of 25.16, whereas SAPIF's P/E ratio is 25.39. In terms of profitability, ACOPY's ROE is +0.16%, compared to SAPIF's ROE of +0.09%. Regarding short-term risk, ACOPY is less volatile compared to SAPIF. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPY.Check SAPIF's competition here
ACOPY vs SDPNF Comparison May 2026
ACOPY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPY stands at 3.3B. In comparison, SDPNF has a market cap of 10.3B. Regarding current trading prices, ACOPY is priced at $4.55, while SDPNF trades at $1.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPY currently has a P/E ratio of 25.16, whereas SDPNF's P/E ratio is 16.55. In terms of profitability, ACOPY's ROE is +0.16%, compared to SDPNF's ROE of +0.14%. Regarding short-term risk, ACOPY is less volatile compared to SDPNF. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPY.Check SDPNF's competition here
ACOPY vs BRZL Comparison May 2026
ACOPY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPY stands at 3.3B. In comparison, BRZL has a market cap of 10.1B. Regarding current trading prices, ACOPY is priced at $4.55, while BRZL trades at $1.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPY currently has a P/E ratio of 25.16, whereas BRZL's P/E ratio is N/A. In terms of profitability, ACOPY's ROE is +0.16%, compared to BRZL's ROE of +0.72%. Regarding short-term risk, ACOPY is less volatile compared to BRZL. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPY.Check BRZL's competition here
ACOPY vs LOTBY Comparison May 2026
ACOPY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPY stands at 3.3B. In comparison, LOTBY has a market cap of 9.3B. Regarding current trading prices, ACOPY is priced at $4.55, while LOTBY trades at $114.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPY currently has a P/E ratio of 25.16, whereas LOTBY's P/E ratio is 45.80. In terms of profitability, ACOPY's ROE is +0.16%, compared to LOTBY's ROE of +0.21%. Regarding short-term risk, ACOPY is less volatile compared to LOTBY. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPY.Check LOTBY's competition here
ACOPY vs TYCMY Comparison May 2026
ACOPY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPY stands at 3.3B. In comparison, TYCMY has a market cap of 9.1B. Regarding current trading prices, ACOPY is priced at $4.55, while TYCMY trades at $32.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPY currently has a P/E ratio of 25.16, whereas TYCMY's P/E ratio is 13.70. In terms of profitability, ACOPY's ROE is +0.16%, compared to TYCMY's ROE of +0.23%. Regarding short-term risk, ACOPY is less volatile compared to TYCMY. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPY.Check TYCMY's competition here
ACOPY vs KIKOY Comparison May 2026
ACOPY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPY stands at 3.3B. In comparison, KIKOY has a market cap of 8.8B. Regarding current trading prices, ACOPY is priced at $4.55, while KIKOY trades at $19.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPY currently has a P/E ratio of 25.16, whereas KIKOY's P/E ratio is 22.62. In terms of profitability, ACOPY's ROE is +0.16%, compared to KIKOY's ROE of +0.12%. Regarding short-term risk, ACOPY and KIKOY have similar daily volatility (0.00).Check KIKOY's competition here
ACOPY vs TTAZF Comparison May 2026
ACOPY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPY stands at 3.3B. In comparison, TTAZF has a market cap of 8.8B. Regarding current trading prices, ACOPY is priced at $4.55, while TTAZF trades at $7.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPY currently has a P/E ratio of 25.16, whereas TTAZF's P/E ratio is 77.60. In terms of profitability, ACOPY's ROE is +0.16%, compared to TTAZF's ROE of N/A. Regarding short-term risk, ACOPY and TTAZF have similar daily volatility (0.00).Check TTAZF's competition here
ACOPY vs CIADY Comparison May 2026
ACOPY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPY stands at 3.3B. In comparison, CIADY has a market cap of 8.7B. Regarding current trading prices, ACOPY is priced at $4.55, while CIADY trades at $22.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPY currently has a P/E ratio of 25.16, whereas CIADY's P/E ratio is 38.79. In terms of profitability, ACOPY's ROE is +0.16%, compared to CIADY's ROE of +0.04%. Regarding short-term risk, ACOPY is less volatile compared to CIADY. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPY.Check CIADY's competition here
ACOPY vs CIADF Comparison May 2026
ACOPY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPY stands at 3.3B. In comparison, CIADF has a market cap of 8.6B. Regarding current trading prices, ACOPY is priced at $4.55, while CIADF trades at $2.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPY currently has a P/E ratio of 25.16, whereas CIADF's P/E ratio is 36.83. In terms of profitability, ACOPY's ROE is +0.16%, compared to CIADF's ROE of +0.04%. Regarding short-term risk, ACOPY is less volatile compared to CIADF. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPY.Check CIADF's competition here
ACOPY vs KIKOF Comparison May 2026
ACOPY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPY stands at 3.3B. In comparison, KIKOF has a market cap of 8.2B. Regarding current trading prices, ACOPY is priced at $4.55, while KIKOF trades at $8.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPY currently has a P/E ratio of 25.16, whereas KIKOF's P/E ratio is 21.19. In terms of profitability, ACOPY's ROE is +0.16%, compared to KIKOF's ROE of +0.12%. Regarding short-term risk, ACOPY and KIKOF have similar daily volatility (0.00).Check KIKOF's competition here
ACOPY vs FNEVY Comparison May 2026
ACOPY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPY stands at 3.3B. In comparison, FNEVY has a market cap of 7.6B. Regarding current trading prices, ACOPY is priced at $4.55, while FNEVY trades at $5.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPY currently has a P/E ratio of 25.16, whereas FNEVY's P/E ratio is 13.00. In terms of profitability, ACOPY's ROE is +0.16%, compared to FNEVY's ROE of +0.05%. Regarding short-term risk, ACOPY and FNEVY have similar daily volatility (0.00).Check FNEVY's competition here
ACOPY vs TSUKF Comparison May 2026
ACOPY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPY stands at 3.3B. In comparison, TSUKF has a market cap of 7.5B. Regarding current trading prices, ACOPY is priced at $4.55, while TSUKF trades at $77.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPY currently has a P/E ratio of 25.16, whereas TSUKF's P/E ratio is 19.28. In terms of profitability, ACOPY's ROE is +0.16%, compared to TSUKF's ROE of +0.13%. Regarding short-term risk, ACOPY is less volatile compared to TSUKF. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPY.Check TSUKF's competition here
ACOPY vs TCYMF Comparison May 2026
ACOPY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPY stands at 3.3B. In comparison, TCYMF has a market cap of 7.3B. Regarding current trading prices, ACOPY is priced at $4.55, while TCYMF trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPY currently has a P/E ratio of 25.16, whereas TCYMF's P/E ratio is 13.00. In terms of profitability, ACOPY's ROE is +0.16%, compared to TCYMF's ROE of +0.23%. Regarding short-term risk, ACOPY and TCYMF have similar daily volatility (0.00).Check TCYMF's competition here
ACOPY vs ARHUF Comparison May 2026
ACOPY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPY stands at 3.3B. In comparison, ARHUF has a market cap of 7B. Regarding current trading prices, ACOPY is priced at $4.55, while ARHUF trades at $26.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPY currently has a P/E ratio of 25.16, whereas ARHUF's P/E ratio is 18.74. In terms of profitability, ACOPY's ROE is +0.16%, compared to ARHUF's ROE of +0.18%. Regarding short-term risk, ACOPY and ARHUF have similar daily volatility (0.00).Check ARHUF's competition here
ACOPY vs SGLJF Comparison May 2026
ACOPY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPY stands at 3.3B. In comparison, SGLJF has a market cap of 7B. Regarding current trading prices, ACOPY is priced at $4.55, while SGLJF trades at $47.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPY currently has a P/E ratio of 25.16, whereas SGLJF's P/E ratio is 39.93. In terms of profitability, ACOPY's ROE is +0.16%, compared to SGLJF's ROE of +0.13%. Regarding short-term risk, ACOPY and SGLJF have similar daily volatility (0.00).Check SGLJF's competition here
ACOPY vs TATYY Comparison May 2026
ACOPY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPY stands at 3.3B. In comparison, TATYY has a market cap of 6.8B. Regarding current trading prices, ACOPY is priced at $4.55, while TATYY trades at $28.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPY currently has a P/E ratio of 25.16, whereas TATYY's P/E ratio is 79.92. In terms of profitability, ACOPY's ROE is +0.16%, compared to TATYY's ROE of +0.02%. Regarding short-term risk, ACOPY is less volatile compared to TATYY. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPY.Check TATYY's competition here
ACOPY vs TSUKY Comparison May 2026
ACOPY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPY stands at 3.3B. In comparison, TSUKY has a market cap of 6.7B. Regarding current trading prices, ACOPY is priced at $4.55, while TSUKY trades at $67.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPY currently has a P/E ratio of 25.16, whereas TSUKY's P/E ratio is 17.23. In terms of profitability, ACOPY's ROE is +0.16%, compared to TSUKY's ROE of +0.13%. Regarding short-term risk, ACOPY is less volatile compared to TSUKY. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPY.Check TSUKY's competition here
ACOPY vs WWNTY Comparison May 2026
ACOPY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPY stands at 3.3B. In comparison, WWNTY has a market cap of 6.6B. Regarding current trading prices, ACOPY is priced at $4.55, while WWNTY trades at $27.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPY currently has a P/E ratio of 25.16, whereas WWNTY's P/E ratio is 10.64. In terms of profitability, ACOPY's ROE is +0.16%, compared to WWNTY's ROE of +0.23%. Regarding short-term risk, ACOPY is less volatile compared to WWNTY. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPY.Check WWNTY's competition here
ACOPY vs DLLFF Comparison May 2026
ACOPY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPY stands at 3.3B. In comparison, DLLFF has a market cap of 6.5B. Regarding current trading prices, ACOPY is priced at $4.55, while DLLFF trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPY currently has a P/E ratio of 25.16, whereas DLLFF's P/E ratio is 14.00. In terms of profitability, ACOPY's ROE is +0.16%, compared to DLLFF's ROE of N/A. Regarding short-term risk, ACOPY and DLLFF have similar daily volatility (0.00).Check DLLFF's competition here
ACOPY vs GCHOY Comparison May 2026
ACOPY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPY stands at 3.3B. In comparison, GCHOY has a market cap of 6.5B. Regarding current trading prices, ACOPY is priced at $4.55, while GCHOY trades at $10.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPY currently has a P/E ratio of 25.16, whereas GCHOY's P/E ratio is 27.31. In terms of profitability, ACOPY's ROE is +0.16%, compared to GCHOY's ROE of +0.13%. Regarding short-term risk, ACOPY is less volatile compared to GCHOY. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPY.Check GCHOY's competition here
ACOPY vs NSLYF Comparison May 2026
ACOPY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPY stands at 3.3B. In comparison, NSLYF has a market cap of 6.4B. Regarding current trading prices, ACOPY is priced at $4.55, while NSLYF trades at $27.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPY currently has a P/E ratio of 25.16, whereas NSLYF's P/E ratio is 59.35. In terms of profitability, ACOPY's ROE is +0.16%, compared to NSLYF's ROE of +0.93%. Regarding short-term risk, ACOPY and NSLYF have similar daily volatility (0.00).Check NSLYF's competition here
ACOPY vs WWNTF Comparison May 2026
ACOPY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPY stands at 3.3B. In comparison, WWNTF has a market cap of 6.4B. Regarding current trading prices, ACOPY is priced at $4.55, while WWNTF trades at $0.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPY currently has a P/E ratio of 25.16, whereas WWNTF's P/E ratio is 10.80. In terms of profitability, ACOPY's ROE is +0.16%, compared to WWNTF's ROE of +0.24%. Regarding short-term risk, ACOPY and WWNTF have similar daily volatility (0.00).Check WWNTF's competition here
ACOPY vs MEJHY Comparison May 2026
ACOPY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPY stands at 3.3B. In comparison, MEJHY has a market cap of 6.4B. Regarding current trading prices, ACOPY is priced at $4.55, while MEJHY trades at $11.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPY currently has a P/E ratio of 25.16, whereas MEJHY's P/E ratio is 22.15. In terms of profitability, ACOPY's ROE is +0.16%, compared to MEJHY's ROE of +0.06%. Regarding short-term risk, ACOPY is less volatile compared to MEJHY. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPY.Check MEJHY's competition here
ACOPY vs GPAGF Comparison May 2026
ACOPY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPY stands at 3.3B. In comparison, GPAGF has a market cap of 6.2B. Regarding current trading prices, ACOPY is priced at $4.55, while GPAGF trades at $18.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPY currently has a P/E ratio of 25.16, whereas GPAGF's P/E ratio is 11.75. In terms of profitability, ACOPY's ROE is +0.16%, compared to GPAGF's ROE of +0.23%. Regarding short-term risk, ACOPY and GPAGF have similar daily volatility (0.00).Check GPAGF's competition here
ACOPY vs GLAPF Comparison May 2026
ACOPY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPY stands at 3.3B. In comparison, GLAPF has a market cap of 5.5B. Regarding current trading prices, ACOPY is priced at $4.55, while GLAPF trades at $22.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPY currently has a P/E ratio of 25.16, whereas GLAPF's P/E ratio is 31.63. In terms of profitability, ACOPY's ROE is +0.16%, compared to GLAPF's ROE of +0.08%. Regarding short-term risk, ACOPY is less volatile compared to GLAPF. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPY.Check GLAPF's competition here
ACOPY vs MEJHF Comparison May 2026
ACOPY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPY stands at 3.3B. In comparison, MEJHF has a market cap of 5.5B. Regarding current trading prices, ACOPY is priced at $4.55, while MEJHF trades at $20.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPY currently has a P/E ratio of 25.16, whereas MEJHF's P/E ratio is 17.02. In terms of profitability, ACOPY's ROE is +0.16%, compared to MEJHF's ROE of +0.05%. Regarding short-term risk, ACOPY is less volatile compared to MEJHF. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPY.Check MEJHF's competition here
ACOPY vs SMPFF Comparison May 2026
ACOPY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPY stands at 3.3B. In comparison, SMPFF has a market cap of 5.2B. Regarding current trading prices, ACOPY is priced at $4.55, while SMPFF trades at $0.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPY currently has a P/E ratio of 25.16, whereas SMPFF's P/E ratio is 13.38. In terms of profitability, ACOPY's ROE is +0.16%, compared to SMPFF's ROE of +0.18%. Regarding short-term risk, ACOPY and SMPFF have similar daily volatility (0.00).Check SMPFF's competition here
ACOPY vs EMLZF Comparison May 2026
ACOPY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPY stands at 3.3B. In comparison, EMLZF has a market cap of 5.2B. Regarding current trading prices, ACOPY is priced at $4.55, while EMLZF trades at $969.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPY currently has a P/E ratio of 25.16, whereas EMLZF's P/E ratio is 18.32. In terms of profitability, ACOPY's ROE is +0.16%, compared to EMLZF's ROE of +0.22%. Regarding short-term risk, ACOPY is less volatile compared to EMLZF. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPY.Check EMLZF's competition here
ACOPY vs ALFFF Comparison May 2026
ACOPY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPY stands at 3.3B. In comparison, ALFFF has a market cap of 5.2B. Regarding current trading prices, ACOPY is priced at $4.55, while ALFFF trades at $0.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPY currently has a P/E ratio of 25.16, whereas ALFFF's P/E ratio is 11.63. In terms of profitability, ACOPY's ROE is +0.16%, compared to ALFFF's ROE of +0.41%. Regarding short-term risk, ACOPY is less volatile compared to ALFFF. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPY.Check ALFFF's competition here
ACOPY vs GLAPY Comparison May 2026
ACOPY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPY stands at 3.3B. In comparison, GLAPY has a market cap of 5B. Regarding current trading prices, ACOPY is priced at $4.55, while GLAPY trades at $102.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPY currently has a P/E ratio of 25.16, whereas GLAPY's P/E ratio is 28.23. In terms of profitability, ACOPY's ROE is +0.16%, compared to GLAPY's ROE of +0.08%. Regarding short-term risk, ACOPY is less volatile compared to GLAPY. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPY.Check GLAPY's competition here
ACOPY vs PIFFY Comparison May 2026
ACOPY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPY stands at 3.3B. In comparison, PIFFY has a market cap of 4.9B. Regarding current trading prices, ACOPY is priced at $4.55, while PIFFY trades at $8.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPY currently has a P/E ratio of 25.16, whereas PIFFY's P/E ratio is 9.40. In terms of profitability, ACOPY's ROE is +0.16%, compared to PIFFY's ROE of +0.18%. Regarding short-term risk, ACOPY is less volatile compared to PIFFY. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPY.Check PIFFY's competition here
ACOPY vs IOIOF Comparison May 2026
ACOPY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPY stands at 3.3B. In comparison, IOIOF has a market cap of 4.8B. Regarding current trading prices, ACOPY is priced at $4.55, while IOIOF trades at $0.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPY currently has a P/E ratio of 25.16, whereas IOIOF's P/E ratio is 12.64. In terms of profitability, ACOPY's ROE is +0.16%, compared to IOIOF's ROE of +0.13%. Regarding short-term risk, ACOPY and IOIOF have similar daily volatility (0.00).Check IOIOF's competition here
ACOPY vs NFPDF Comparison May 2026
ACOPY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPY stands at 3.3B. In comparison, NFPDF has a market cap of 4.7B. Regarding current trading prices, ACOPY is priced at $4.55, while NFPDF trades at $16.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPY currently has a P/E ratio of 25.16, whereas NFPDF's P/E ratio is 15.72. In terms of profitability, ACOPY's ROE is +0.16%, compared to NFPDF's ROE of +0.12%. Regarding short-term risk, ACOPY and NFPDF have similar daily volatility (0.00).Check NFPDF's competition here
ACOPY vs PIFMF Comparison May 2026
ACOPY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPY stands at 3.3B. In comparison, PIFMF has a market cap of 4.4B. Regarding current trading prices, ACOPY is priced at $4.55, while PIFMF trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPY currently has a P/E ratio of 25.16, whereas PIFMF's P/E ratio is 10.00. In terms of profitability, ACOPY's ROE is +0.16%, compared to PIFMF's ROE of +0.15%. Regarding short-term risk, ACOPY and PIFMF have similar daily volatility (0.00).Check PIFMF's competition here
ACOPY vs CFEIY Comparison May 2026
ACOPY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPY stands at 3.3B. In comparison, CFEIY has a market cap of 4B. Regarding current trading prices, ACOPY is priced at $4.55, while CFEIY trades at $4.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPY currently has a P/E ratio of 25.16, whereas CFEIY's P/E ratio is 14.16. In terms of profitability, ACOPY's ROE is +0.16%, compared to CFEIY's ROE of +0.08%. Regarding short-term risk, ACOPY and CFEIY have similar daily volatility (0.00).Check CFEIY's competition here
ACOPY vs NIPMY Comparison May 2026
ACOPY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPY stands at 3.3B. In comparison, NIPMY has a market cap of 4B. Regarding current trading prices, ACOPY is priced at $4.55, while NIPMY trades at $21.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPY currently has a P/E ratio of 25.16, whereas NIPMY's P/E ratio is 20.39. In terms of profitability, ACOPY's ROE is +0.16%, compared to NIPMY's ROE of +0.07%. Regarding short-term risk, ACOPY and NIPMY have similar daily volatility (0.00).Check NIPMY's competition here
ACOPY vs CHFLF Comparison May 2026
ACOPY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPY stands at 3.3B. In comparison, CHFLF has a market cap of 3.8B. Regarding current trading prices, ACOPY is priced at $4.55, while CHFLF trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPY currently has a P/E ratio of 25.16, whereas CHFLF's P/E ratio is 14.46. In terms of profitability, ACOPY's ROE is +0.16%, compared to CHFLF's ROE of +0.08%. Regarding short-term risk, ACOPY is less volatile compared to CHFLF. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPY.Check CHFLF's competition here
ACOPY vs CRWKF Comparison May 2026
ACOPY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPY stands at 3.3B. In comparison, CRWKF has a market cap of 3.7B. Regarding current trading prices, ACOPY is priced at $4.55, while CRWKF trades at $69.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPY currently has a P/E ratio of 25.16, whereas CRWKF's P/E ratio is 18.76. In terms of profitability, ACOPY's ROE is +0.16%, compared to CRWKF's ROE of +0.15%. Regarding short-term risk, ACOPY is less volatile compared to CRWKF. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPY.Check CRWKF's competition here
ACOPY vs ACOPF Comparison May 2026
ACOPY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPY stands at 3.3B. In comparison, ACOPF has a market cap of 3.6B. Regarding current trading prices, ACOPY is priced at $4.55, while ACOPF trades at $5.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPY currently has a P/E ratio of 25.16, whereas ACOPF's P/E ratio is 27.78. In terms of profitability, ACOPY's ROE is +0.16%, compared to ACOPF's ROE of +0.16%. Regarding short-term risk, ACOPY and ACOPF have similar daily volatility (0.00).Check ACOPF's competition here
ACOPY vs YMZBY Comparison May 2026
ACOPY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPY stands at 3.3B. In comparison, YMZBY has a market cap of 3.5B. Regarding current trading prices, ACOPY is priced at $4.55, while YMZBY trades at $180.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPY currently has a P/E ratio of 25.16, whereas YMZBY's P/E ratio is 14.08. In terms of profitability, ACOPY's ROE is +0.16%, compared to YMZBY's ROE of +0.10%. Regarding short-term risk, ACOPY is less volatile compared to YMZBY. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPY.Check YMZBY's competition here
ACOPY vs PIFMY Comparison May 2026
ACOPY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPY stands at 3.3B. In comparison, PIFMY has a market cap of 3.4B. Regarding current trading prices, ACOPY is priced at $4.55, while PIFMY trades at $19.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPY currently has a P/E ratio of 25.16, whereas PIFMY's P/E ratio is 5.42. In terms of profitability, ACOPY's ROE is +0.16%, compared to PIFMY's ROE of +0.15%. Regarding short-term risk, ACOPY is less volatile compared to PIFMY. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPY.Check PIFMY's competition here
ACOPY vs EBRPF Comparison May 2026
ACOPY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPY stands at 3.3B. In comparison, EBRPF has a market cap of 3.3B. Regarding current trading prices, ACOPY is priced at $4.55, while EBRPF trades at $21.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPY currently has a P/E ratio of 25.16, whereas EBRPF's P/E ratio is 14.19. In terms of profitability, ACOPY's ROE is +0.16%, compared to EBRPF's ROE of +0.09%. Regarding short-term risk, ACOPY and EBRPF have similar daily volatility (0.00).Check EBRPF's competition here
ACOPY vs NSFMF Comparison May 2026
ACOPY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPY stands at 3.3B. In comparison, NSFMF has a market cap of 3.2B. Regarding current trading prices, ACOPY is priced at $4.55, while NSFMF trades at $11.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPY currently has a P/E ratio of 25.16, whereas NSFMF's P/E ratio is 14.20. In terms of profitability, ACOPY's ROE is +0.16%, compared to NSFMF's ROE of +0.06%. Regarding short-term risk, ACOPY is less volatile compared to NSFMF. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPY.Check NSFMF's competition here
ACOPY vs TBLMF Comparison May 2026
ACOPY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPY stands at 3.3B. In comparison, TBLMF has a market cap of 3.2B. Regarding current trading prices, ACOPY is priced at $4.55, while TBLMF trades at $20.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPY currently has a P/E ratio of 25.16, whereas TBLMF's P/E ratio is 12.97. In terms of profitability, ACOPY's ROE is +0.16%, compared to TBLMF's ROE of +0.21%. Regarding short-term risk, ACOPY is less volatile compared to TBLMF. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPY.Check TBLMF's competition here
ACOPY vs NHFOF Comparison May 2026
ACOPY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPY stands at 3.3B. In comparison, NHFOF has a market cap of 3.1B. Regarding current trading prices, ACOPY is priced at $4.55, while NHFOF trades at $33.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPY currently has a P/E ratio of 25.16, whereas NHFOF's P/E ratio is 18.54. In terms of profitability, ACOPY's ROE is +0.16%, compared to NHFOF's ROE of +0.07%. Regarding short-term risk, ACOPY is less volatile compared to NHFOF. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPY.Check NHFOF's competition here
ACOPY vs NCHEY Comparison May 2026
ACOPY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPY stands at 3.3B. In comparison, NCHEY has a market cap of 3.1B. Regarding current trading prices, ACOPY is priced at $4.55, while NCHEY trades at $12.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPY currently has a P/E ratio of 25.16, whereas NCHEY's P/E ratio is 18.06. In terms of profitability, ACOPY's ROE is +0.16%, compared to NCHEY's ROE of +0.10%. Regarding short-term risk, ACOPY is less volatile compared to NCHEY. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPY.Check NCHEY's competition here
ACOPY vs FPAFY Comparison May 2026
ACOPY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPY stands at 3.3B. In comparison, FPAFY has a market cap of 3B. Regarding current trading prices, ACOPY is priced at $4.55, while FPAFY trades at $3.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPY currently has a P/E ratio of 25.16, whereas FPAFY's P/E ratio is 4.66. In terms of profitability, ACOPY's ROE is +0.16%, compared to FPAFY's ROE of +0.15%. Regarding short-term risk, ACOPY is less volatile compared to FPAFY. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPY.Check FPAFY's competition here
ACOPY vs FPAFF Comparison May 2026
ACOPY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPY stands at 3.3B. In comparison, FPAFF has a market cap of 3B. Regarding current trading prices, ACOPY is priced at $4.55, while FPAFF trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPY currently has a P/E ratio of 25.16, whereas FPAFF's P/E ratio is 4.67. In terms of profitability, ACOPY's ROE is +0.16%, compared to FPAFF's ROE of +0.15%. Regarding short-term risk, ACOPY is less volatile compared to FPAFF. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPY.Check FPAFF's competition here
ACOPY vs LYSFF Comparison May 2026
ACOPY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPY stands at 3.3B. In comparison, LYSFF has a market cap of 2.9B. Regarding current trading prices, ACOPY is priced at $4.55, while LYSFF trades at $4.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPY currently has a P/E ratio of 25.16, whereas LYSFF's P/E ratio is 26.05. In terms of profitability, ACOPY's ROE is +0.16%, compared to LYSFF's ROE of +0.06%. Regarding short-term risk, ACOPY and LYSFF have similar daily volatility (0.00).Check LYSFF's competition here
ACOPY vs LYSFY Comparison May 2026
ACOPY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPY stands at 3.3B. In comparison, LYSFY has a market cap of 2.9B. Regarding current trading prices, ACOPY is priced at $4.55, while LYSFY trades at $9.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPY currently has a P/E ratio of 25.16, whereas LYSFY's P/E ratio is 25.79. In terms of profitability, ACOPY's ROE is +0.16%, compared to LYSFY's ROE of +0.06%. Regarding short-term risk, ACOPY and LYSFY have similar daily volatility (0.00).Check LYSFY's competition here
ACOPY vs MRRTY Comparison May 2026
ACOPY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPY stands at 3.3B. In comparison, MRRTY has a market cap of 2.9B. Regarding current trading prices, ACOPY is priced at $4.55, while MRRTY trades at $3.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPY currently has a P/E ratio of 25.16, whereas MRRTY's P/E ratio is 11.03. In terms of profitability, ACOPY's ROE is +0.16%, compared to MRRTY's ROE of +0.97%. Regarding short-term risk, ACOPY is less volatile compared to MRRTY. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPY.Check MRRTY's competition here
ACOPY vs PRBZF Comparison May 2026
ACOPY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPY stands at 3.3B. In comparison, PRBZF has a market cap of 2.8B. Regarding current trading prices, ACOPY is priced at $4.55, while PRBZF trades at $62.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPY currently has a P/E ratio of 25.16, whereas PRBZF's P/E ratio is 98.16. In terms of profitability, ACOPY's ROE is +0.16%, compared to PRBZF's ROE of +0.02%. Regarding short-term risk, ACOPY is less volatile compared to PRBZF. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPY.Check PRBZF's competition here
ACOPY vs CBCFF Comparison May 2026
ACOPY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPY stands at 3.3B. In comparison, CBCFF has a market cap of 2.8B. Regarding current trading prices, ACOPY is priced at $4.55, while CBCFF trades at $23.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPY currently has a P/E ratio of 25.16, whereas CBCFF's P/E ratio is 21.90. In terms of profitability, ACOPY's ROE is +0.16%, compared to CBCFF's ROE of +0.08%. Regarding short-term risk, ACOPY is less volatile compared to CBCFF. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPY.Check CBCFF's competition here
ACOPY vs SUEZY Comparison May 2026
ACOPY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPY stands at 3.3B. In comparison, SUEZY has a market cap of 2.8B. Regarding current trading prices, ACOPY is priced at $4.55, while SUEZY trades at $6.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPY currently has a P/E ratio of 25.16, whereas SUEZY's P/E ratio is -12.36. In terms of profitability, ACOPY's ROE is +0.16%, compared to SUEZY's ROE of -0.06%. Regarding short-term risk, ACOPY and SUEZY have similar daily volatility (0.00).Check SUEZY's competition here
ACOPY vs EBRPY Comparison May 2026
ACOPY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPY stands at 3.3B. In comparison, EBRPY has a market cap of 2.8B. Regarding current trading prices, ACOPY is priced at $4.55, while EBRPY trades at $17.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPY currently has a P/E ratio of 25.16, whereas EBRPY's P/E ratio is 20.34. In terms of profitability, ACOPY's ROE is +0.16%, compared to EBRPY's ROE of +0.06%. Regarding short-term risk, ACOPY and EBRPY have similar daily volatility (0.00).Check EBRPY's competition here
ACOPY vs NISUY Comparison May 2026
ACOPY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPY stands at 3.3B. In comparison, NISUY has a market cap of 2.6B. Regarding current trading prices, ACOPY is priced at $4.55, while NISUY trades at $86.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPY currently has a P/E ratio of 25.16, whereas NISUY's P/E ratio is 15.17. In terms of profitability, ACOPY's ROE is +0.16%, compared to NISUY's ROE of +0.10%. Regarding short-term risk, ACOPY is less volatile compared to NISUY. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPY.Check NISUY's competition here
ACOPY vs MLFNF Comparison May 2026
ACOPY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPY stands at 3.3B. In comparison, MLFNF has a market cap of 2.5B. Regarding current trading prices, ACOPY is priced at $4.55, while MLFNF trades at $20.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPY currently has a P/E ratio of 25.16, whereas MLFNF's P/E ratio is 48.40. In terms of profitability, ACOPY's ROE is +0.16%, compared to MLFNF's ROE of +0.37%. Regarding short-term risk, ACOPY and MLFNF have similar daily volatility (0.00).Check MLFNF's competition here
ACOPY vs SUEZF Comparison May 2026
ACOPY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPY stands at 3.3B. In comparison, SUEZF has a market cap of 2.5B. Regarding current trading prices, ACOPY is priced at $4.55, while SUEZF trades at $12.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPY currently has a P/E ratio of 25.16, whereas SUEZF's P/E ratio is -11.03. In terms of profitability, ACOPY's ROE is +0.16%, compared to SUEZF's ROE of -0.06%. Regarding short-term risk, ACOPY is less volatile compared to SUEZF. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPY.Check SUEZF's competition here
ACOPY vs PRRFY Comparison May 2026
ACOPY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPY stands at 3.3B. In comparison, PRRFY has a market cap of 2.4B. Regarding current trading prices, ACOPY is priced at $4.55, while PRRFY trades at $13.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPY currently has a P/E ratio of 25.16, whereas PRRFY's P/E ratio is 13.69. In terms of profitability, ACOPY's ROE is +0.16%, compared to PRRFY's ROE of +0.12%. Regarding short-term risk, ACOPY is less volatile compared to PRRFY. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPY.Check PRRFY's competition here
ACOPY vs TATYF Comparison May 2026
ACOPY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPY stands at 3.3B. In comparison, TATYF has a market cap of 2.2B. Regarding current trading prices, ACOPY is priced at $4.55, while TATYF trades at $7.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPY currently has a P/E ratio of 25.16, whereas TATYF's P/E ratio is 55.56. In terms of profitability, ACOPY's ROE is +0.16%, compared to TATYF's ROE of +0.02%. Regarding short-term risk, ACOPY and TATYF have similar daily volatility (0.00).Check TATYF's competition here
ACOPY vs CLBEY Comparison May 2026
ACOPY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPY stands at 3.3B. In comparison, CLBEY has a market cap of 2.2B. Regarding current trading prices, ACOPY is priced at $4.55, while CLBEY trades at $4.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPY currently has a P/E ratio of 25.16, whereas CLBEY's P/E ratio is 20.57. In terms of profitability, ACOPY's ROE is +0.16%, compared to CLBEY's ROE of +0.08%. Regarding short-term risk, ACOPY and CLBEY have similar daily volatility (0.00).Check CLBEY's competition here
ACOPY vs UVRBF Comparison May 2026
ACOPY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPY stands at 3.3B. In comparison, UVRBF has a market cap of 2.1B. Regarding current trading prices, ACOPY is priced at $4.55, while UVRBF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPY currently has a P/E ratio of 25.16, whereas UVRBF's P/E ratio is 12.50. In terms of profitability, ACOPY's ROE is +0.16%, compared to UVRBF's ROE of +0.08%. Regarding short-term risk, ACOPY and UVRBF have similar daily volatility (0.00).Check UVRBF's competition here
ACOPY vs PFODF Comparison May 2026
ACOPY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPY stands at 3.3B. In comparison, PFODF has a market cap of 2.1B. Regarding current trading prices, ACOPY is priced at $4.55, while PFODF trades at $2.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPY currently has a P/E ratio of 25.16, whereas PFODF's P/E ratio is 11.52. In terms of profitability, ACOPY's ROE is +0.16%, compared to PFODF's ROE of +0.16%. Regarding short-term risk, ACOPY is less volatile compared to PFODF. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPY.Check PFODF's competition here
ACOPY vs GRPBF Comparison May 2026
ACOPY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPY stands at 3.3B. In comparison, GRPBF has a market cap of 2.1B. Regarding current trading prices, ACOPY is priced at $4.55, while GRPBF trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPY currently has a P/E ratio of 25.16, whereas GRPBF's P/E ratio is N/A. In terms of profitability, ACOPY's ROE is +0.16%, compared to GRPBF's ROE of N/A. Regarding short-term risk, ACOPY and GRPBF have similar daily volatility (0.00).Check GRPBF's competition here
ACOPY vs ARZTY Comparison May 2026
ACOPY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPY stands at 3.3B. In comparison, ARZTY has a market cap of 2B. Regarding current trading prices, ACOPY is priced at $4.55, while ARZTY trades at $7.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPY currently has a P/E ratio of 25.16, whereas ARZTY's P/E ratio is 14.98. In terms of profitability, ACOPY's ROE is +0.16%, compared to ARZTY's ROE of +0.22%. Regarding short-term risk, ACOPY and ARZTY have similar daily volatility (0.00).Check ARZTY's competition here
ACOPY vs YNNHF Comparison May 2026
ACOPY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPY stands at 3.3B. In comparison, YNNHF has a market cap of 1.9B. Regarding current trading prices, ACOPY is priced at $4.55, while YNNHF trades at $1.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPY currently has a P/E ratio of 25.16, whereas YNNHF's P/E ratio is 15.32. In terms of profitability, ACOPY's ROE is +0.16%, compared to YNNHF's ROE of +0.18%. Regarding short-term risk, ACOPY is less volatile compared to YNNHF. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPY.Check YNNHF's competition here
ACOPY vs ARZTF Comparison May 2026
ACOPY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPY stands at 3.3B. In comparison, ARZTF has a market cap of 1.9B. Regarding current trading prices, ACOPY is priced at $4.55, while ARZTF trades at $62.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPY currently has a P/E ratio of 25.16, whereas ARZTF's P/E ratio is 522.33. In terms of profitability, ACOPY's ROE is +0.16%, compared to ARZTF's ROE of +0.23%. Regarding short-term risk, ACOPY and ARZTF have similar daily volatility (0.00).Check ARZTF's competition here
ACOPY vs UVRBY Comparison May 2026
ACOPY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPY stands at 3.3B. In comparison, UVRBY has a market cap of 1.8B. Regarding current trading prices, ACOPY is priced at $4.55, while UVRBY trades at $8.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPY currently has a P/E ratio of 25.16, whereas UVRBY's P/E ratio is 11.18. In terms of profitability, ACOPY's ROE is +0.16%, compared to UVRBY's ROE of +0.08%. Regarding short-term risk, ACOPY is less volatile compared to UVRBY. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPY.Check UVRBY's competition here
ACOPY vs HOFJF Comparison May 2026
ACOPY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPY stands at 3.3B. In comparison, HOFJF has a market cap of 1.8B. Regarding current trading prices, ACOPY is priced at $4.55, while HOFJF trades at $19.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPY currently has a P/E ratio of 25.16, whereas HOFJF's P/E ratio is 23.90. In terms of profitability, ACOPY's ROE is +0.16%, compared to HOFJF's ROE of +0.03%. Regarding short-term risk, ACOPY is less volatile compared to HOFJF. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPY.Check HOFJF's competition here
ACOPY vs TBLMY Comparison May 2026
ACOPY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPY stands at 3.3B. In comparison, TBLMY has a market cap of 1.7B. Regarding current trading prices, ACOPY is priced at $4.55, while TBLMY trades at $10.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPY currently has a P/E ratio of 25.16, whereas TBLMY's P/E ratio is 12.02. In terms of profitability, ACOPY's ROE is +0.16%, compared to TBLMY's ROE of +0.17%. Regarding short-term risk, ACOPY and TBLMY have similar daily volatility (0.00).Check TBLMY's competition here
ACOPY vs AVSFY Comparison May 2026
ACOPY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPY stands at 3.3B. In comparison, AVSFY has a market cap of 1.7B. Regarding current trading prices, ACOPY is priced at $4.55, while AVSFY trades at $25.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPY currently has a P/E ratio of 25.16, whereas AVSFY's P/E ratio is 12.32. In terms of profitability, ACOPY's ROE is +0.16%, compared to AVSFY's ROE of +0.46%. Regarding short-term risk, ACOPY and AVSFY have similar daily volatility (0.00).Check AVSFY's competition here
ACOPY vs FNEVF Comparison May 2026
ACOPY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPY stands at 3.3B. In comparison, FNEVF has a market cap of 1.7B. Regarding current trading prices, ACOPY is priced at $4.55, while FNEVF trades at $1.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPY currently has a P/E ratio of 25.16, whereas FNEVF's P/E ratio is 14.25. In terms of profitability, ACOPY's ROE is +0.16%, compared to FNEVF's ROE of +0.04%. Regarding short-term risk, ACOPY is less volatile compared to FNEVF. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPY.Check FNEVF's competition here
ACOPY vs GNCGF Comparison May 2026
ACOPY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPY stands at 3.3B. In comparison, GNCGF has a market cap of 1.4B. Regarding current trading prices, ACOPY is priced at $4.55, while GNCGF trades at $3.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPY currently has a P/E ratio of 25.16, whereas GNCGF's P/E ratio is 19.53. In terms of profitability, ACOPY's ROE is +0.16%, compared to GNCGF's ROE of +0.12%. Regarding short-term risk, ACOPY is less volatile compared to GNCGF. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPY.Check GNCGF's competition here
ACOPY vs HLFGY Comparison May 2026
ACOPY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPY stands at 3.3B. In comparison, HLFGY has a market cap of 1.4B. Regarding current trading prices, ACOPY is priced at $4.55, while HLFGY trades at $15.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPY currently has a P/E ratio of 25.16, whereas HLFGY's P/E ratio is 24.16. In terms of profitability, ACOPY's ROE is +0.16%, compared to HLFGY's ROE of +0.16%. Regarding short-term risk, ACOPY is less volatile compared to HLFGY. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPY.Check HLFGY's competition here
ACOPY vs TUFBY Comparison May 2026
ACOPY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPY stands at 3.3B. In comparison, TUFBY has a market cap of 1.4B. Regarding current trading prices, ACOPY is priced at $4.55, while TUFBY trades at $7.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPY currently has a P/E ratio of 25.16, whereas TUFBY's P/E ratio is 9.53. In terms of profitability, ACOPY's ROE is +0.16%, compared to TUFBY's ROE of +0.10%. Regarding short-term risk, ACOPY and TUFBY have similar daily volatility (0.00).Check TUFBY's competition here
ACOPY vs GNCGY Comparison May 2026
ACOPY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPY stands at 3.3B. In comparison, GNCGY has a market cap of 1.4B. Regarding current trading prices, ACOPY is priced at $4.55, while GNCGY trades at $12.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPY currently has a P/E ratio of 25.16, whereas GNCGY's P/E ratio is 18.30. In terms of profitability, ACOPY's ROE is +0.16%, compared to GNCGY's ROE of +0.12%. Regarding short-term risk, ACOPY and GNCGY have similar daily volatility (0.00).Check GNCGY's competition here
ACOPY vs AKEJF Comparison May 2026
ACOPY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPY stands at 3.3B. In comparison, AKEJF has a market cap of 1.2B. Regarding current trading prices, ACOPY is priced at $4.55, while AKEJF trades at $37.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPY currently has a P/E ratio of 25.16, whereas AKEJF's P/E ratio is 19.73. In terms of profitability, ACOPY's ROE is +0.16%, compared to AKEJF's ROE of +0.06%. Regarding short-term risk, ACOPY is less volatile compared to AKEJF. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPY.Check AKEJF's competition here
ACOPY vs GUZOF Comparison May 2026
ACOPY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPY stands at 3.3B. In comparison, GUZOF has a market cap of 1.2B. Regarding current trading prices, ACOPY is priced at $4.55, while GUZOF trades at $3.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPY currently has a P/E ratio of 25.16, whereas GUZOF's P/E ratio is 11.79. In terms of profitability, ACOPY's ROE is +0.16%, compared to GUZOF's ROE of +2.38%. Regarding short-term risk, ACOPY is less volatile compared to GUZOF. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPY.Check GUZOF's competition here
ACOPY vs TUFUF Comparison May 2026
ACOPY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPY stands at 3.3B. In comparison, TUFUF has a market cap of 1.1B. Regarding current trading prices, ACOPY is priced at $4.55, while TUFUF trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPY currently has a P/E ratio of 25.16, whereas TUFUF's P/E ratio is 7.07. In terms of profitability, ACOPY's ROE is +0.16%, compared to TUFUF's ROE of +0.10%. Regarding short-term risk, ACOPY is less volatile compared to TUFUF. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPY.Check TUFUF's competition here
ACOPY vs GBFBF Comparison May 2026
ACOPY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPY stands at 3.3B. In comparison, GBFBF has a market cap of 1.1B. Regarding current trading prices, ACOPY is priced at $4.55, while GBFBF trades at $2.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPY currently has a P/E ratio of 25.16, whereas GBFBF's P/E ratio is 12.38. In terms of profitability, ACOPY's ROE is +0.16%, compared to GBFBF's ROE of N/A. Regarding short-term risk, ACOPY and GBFBF have similar daily volatility (0.00).Check GBFBF's competition here
ACOPY vs BTSDF Comparison May 2026
ACOPY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPY stands at 3.3B. In comparison, BTSDF has a market cap of 1B. Regarding current trading prices, ACOPY is priced at $4.55, while BTSDF trades at $1.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPY currently has a P/E ratio of 25.16, whereas BTSDF's P/E ratio is 32.00. In terms of profitability, ACOPY's ROE is +0.16%, compared to BTSDF's ROE of +0.03%. Regarding short-term risk, ACOPY and BTSDF have similar daily volatility (0.00).Check BTSDF's competition here